胃と腸40巻7号

2005年06月発行

今月の主題 胃癌化学療法の進歩と課題 主題

胃癌の術後補助化学療法と術前化学療法―有効性の検証

著者： 梨本篤¹

所属機関： ¹新潟県立がんセンター新潟病院外科

ページ範囲：P.999 - P.1013

要旨　欧米では術後補助化学療法に関しメタアナリシスにて有効性が示されたが，比較的大規模なRCTでも単一の試験においては手術単独に対する胃癌補助化学療法の優位性が証明されていない．本邦でも漿膜浸潤陰性および漿膜浸潤陽性症例を対象としたJCOG臨床試験にて，術後補助化学療法の有効性は検証されなかった．したがって，現時点では標準治療となるべき特定の術後補助化学療法を推奨することはできない．術前治療に関しては，米国では根治術が困難な高度進行胃癌に対し術前放射線化学療法の有効性が示唆され，欧州ではMAGIC trial後，術前化学療法の有効性を検証する大規模第III相試験が始まっている．本邦でも新薬の出現，強力な術前化学療法により，down staging，MSTの改善は得られてきている．特にTS-1＋CDDP療法は有害事象が比較的軽度，奏効率が高率で，期待できる治療法である．新規臨床試験としては，術後のコンプライアンスの低さを克服する点で，術前投与にパラダイムシフトする傾向がある．

参考文献

1）Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer : meta-analysis of randomized trials. J Clin Oncol 11 : 1441-1447, 1993

2）Hermans J, Bonenkamp JJ. In reply to the editor. J Clin Oncol 12 : 878-880, 1994

3）Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients : Revisiting a meta-analysis of randomized trials. Eur J Cancer 35 : 1059-1064, 1999

4）Panzini I, Gianni L, Fattori PP, et al. Adjuvant chemotherapy in gastric cancer : a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 88 : 21-27, 2002

5）Mari E, Floriani I, Tinazzi A, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomized trials. A study of the GISCAD（Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente）. Ann Oncol 11 : 837-843, 2000

6）Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric caner : a review and updated meta-analysis. Eur J Surg 168 : 597-608, 2002

7）Hu JK, Chen ZX, Zhou ZG, et al. Intravenous chemotherapy for resected gastric cancer. Meta-analysis of randomized controlled trials. World J Gastroenterol 8 : 1023-1028, 2002

8）Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 : 725-730, 2001

9）Macdonald JS, Smalley SR, Benedetti J, et al. Subset analyses, SWOG 9008/INT 0116. ASCO-GI meeting, San Francisco, 2004

10）Neri B, Cini G, Andreoli F, et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer. 5-year follow-up. Br J Cancer 84 : 875-877, 2001

11）Ducreux M, Nordlinger B, Ychou M, et al. Resected gastric adenocarcinoma : randomized trial of adjuvant chemotherapy with 5FU-cisplatin（FUP）. Final results of the FFCD 8801 trial. Proc ASCO 19 : 241a（abstr 932）, 2000

12）Bajetta E, Buzzoni R, Mariani L, et al. Adjuvant chemotherapy in gastric cancer : 5-year results of a randomized study by the Italian Trials in Medical Oncology （ITMO）Group. Ann Oncol 13 : 299-307, 2002

13）Wils J, Nitti D, Guimaraes-Dos-Santos J, et al. Randomized phase III studies of adjuvant chemotherapy with FAMTX or FEMTX in resected gastric cancer. Pooled results of studies from the EORTC GI-group and the ICCG. Proc ASCO 21 : 131a（abstr 521）, 2002

14）Di Constanzo F, Gasperoni L, Manzione, M, et al. Postoperative chemotherapy（CT）in resected gastric cancer（GC）: follow-up（FUP）vs PELF. Results of an Italian intergroup（GOIRC & GISCAD）study. Proc ASCO 22 : 296（abstr 1189）, 2003

15）今永一，中里博昭．3 つのprospective controlled study その1．臨外 36 : 175-183, 1981

16）木村正，小山善之．3 つのprospective controlled study その2．臨外 36 : 185-195, 1981

17）中島聰總，太田惠一朗，石原省．Meta-analysisによる胃癌術後補助化学療法の再評価．癌と化学療法 21 : 1800-1805, 1994

18）Nakazato H, Koike K, Saji S, et al. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343 : 1122-1226, 1994

19）Sakamoto J, Teramukai S, Nakazato H, et al. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer : a meta-analysis of centrally randomized controlled clinical trials. J Immunother 25 : 405-412, 2002

20）中島聡総，岡林謙蔵，中里博昭，他．胃癌治癒手術症例に対するMFC療法を中心とした補助化学療法の治療効果．日癌治療会誌 29 : 654-662, 1994

21）Nakajima T, Nashimoto A, Kitamura M, et al. Adjuvant mitomycin C and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer : a randomized trial. Lancet 354 : 273-277, 1999

22）Nashimoto A, Nakajima T, Furukawa H, et al. A randomized trial of adjuvant chemotherapy with MFC followed by oral fluorouracil in serosa-negative gastric cancer : JCOG Study 9206 1. J Clin Oncol 21 : 2282-2287, 2003

23）Miyashiro I, Furukawa H, Sasako M, et al. Randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil （UFT）in serosa-positive gastric cancer. Japan Clinical Oncology Group 9206-2. Proc 2nd ASCO-GI Meeting 2 : 84（abstr 4）, 2005

24）日本胃癌学会（編）．胃癌治療ガイドライン（医師用，第2 版）．金原出版，2004

25）Frei III E. Clinical Cancer Research : An Embattled Species. Cancer 50 : 1979-1992, 1982

26）Trimble EL, Ungerleider RS, Abrams JA, et al. Neoadjuvant therapy in cancer treatment. Cancer 72 : 3515-3524, 1993

27）Glasser DB, Lane JM, Huvos AG, et al. Survival, prognosis, and therapeutic response in osteogenic sarcoma : the Memorial Hospital experience. Cancer 69 : 698-708, 1992

28）Wilke H, Preusser P, Fink U, et al. Preoperative Chemotherapy in locally advanced and nonresectable gastric cancer : a phase II study with etopiside, doxorubicin, and cisplatin. J Clin Oncol 7 : 1318-1326, 1989

29）Yonemura Y, Sawa T, Kinosita K, et al. Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17 : 256-262, 1993

30）Kelsen D, Karpeh M, Schwartz G, et al. Neoadjuvant therapy of high-risk gastric cancer : A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14 : 1818-1828, 1996

31）Melcher AA, Mort D, Maughan TS. Epirubicin, cisplatin and continuous infusion 5-fluorouracil（ECF）as neoadjuvant chemotherapy in gastro-esophageal cancer. Br J Cancer 74 : 1651-1654, 1996

32）Crookes P, Leichman C, Leichman L, et al. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy. a final report. Cancer 79 : 1767-1775, 1997

33）Nakajima T, Ota K, Ishihara S, et al. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol 4 : 203-208, 1997

34）Lowy AM, Mansfield PF, Leach SD, et al. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 229 : 303-308, 1999

35）Songun I, Keizer HJ, Hermans J, et al. Chemotherapy for operable gastric cancer. Results of the Dutch randomized FAMTX trial. The Dutch Gastric Cancer Group(DGCG）. Eur J Cancer 35 : 558-562, 1999

36）Ajani JA, Mansfield PF, Lynch PM, et al. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric cancer. J Clin Oncol 17 : 2403-2411, 1999

37）Nashimoto A, Yabusiki H, Tanaka O, et al. Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors : a phase II study with 5-fluorouracil, leucovorin, and cisplatin. Gastric Cancer 2 : 57-63, 1999

38）Gallardo-Rincon D, Onate-Ocana LF, Calderrillo-Ruiz G : Neoadjuvant chemotherapy with P-ELF（Cisplatin, etoposide, leucovorin, 5 fluorouracil）followed by radical resection in patients with initially unresectable gastric adenocarcinoma. A phase II study. Ann Surg Oncol 7 : 45-50, 2000

39）Newman E, Marcus SG, Potmesil M, et al. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J Gastrointest Surg 6 : 212-223, 2002

40）Yano M, Shiozaki H, Inoue M, et al. Neoadjuvant chemotherapy followed by salvage surgery : effect on survival of patients with primary noncurative gastric cancer. World J Surg 26 : 1155-1159, 2002

41）Ott K, Sendler A, Becker K, et al. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin（PLF）locally advanced gastric cancer. A prospective phase II study. Gastric Cancer 6 : 131-133, 2003

42）Ajani JA, Mansfield PF, Janjan N, et al. Multiinstitutional trial of preoperative chemoradiotherapy in patients with potentially respectable gastric carcinoma. J Clin Oncol 22 : 2774-2780, 2004

43）Ajani JA, Mansfield PF, Crane TT, et al. Paclitaxelbased chemotherapy in localized gastric carcinoma : degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23 : 1237-1244, 2005

44）Allum W, Cunningham D, Weeden S, et al. Preoperative chemotherapy in operable gastric and lower esophageal cancer. A randomized controlled trial（the MAGIC trial, ISRCTN 93793971）. Proc ASCO 22 : 249（abstr 998）, 2003

45）Tsuburaya A, Sasako M, Furukawa H, et al. Preoperative adjuvant chemotherapy with irinotecan and cisplatin for gastric cancer with extensive lymph node metastasis : A multicenter phase II study by Japan Clinical Oncology Group（JCOG 0001）. Proc 2nd ASCO-GI Meeting 2 : 84（abstr 3）, 2005

46）Koizumi W, Tanabe S, Saigenji K, et al. Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89 : 2207-2212, 2003